Member Info for londondan

Indeed Mozak. Haleon's presence and clear interest in the product is one of the main reasons for my confidence here. Good to see the tedious day trader ramp crew seems to have shuffled off to the next pump. This isn't that kind of company.

Really good to see some positive activity here. I've been waiting for the market to catch up ever since I bought these. Feels like a big opportunity that has been flying under the radar until now.

I've just been trying to work out the same. There'll be a point at which this becomes greatly oversold.

Haleon being the U.S. launch partner doesn't get enough attention. This isn't an amateur operation having a go at cracking the U.S., it's the former GSK consumer health business; a FTSE100 company with Sensodyne, Voltarol, Advil, Panadol, Centrum etc. etc. in its portfolio. There aren't many better partners for us to be involved with, in opening up this key market.

Nice update and I'm glad to be invested here. The team isn't the best at banging its own drum, but it's tough to argue with results, which are now ticking through nicely. Onwards and upwards.

Too true HITS. I can't see even the most devoted supporter still trying to make excuses for him at this point. Surely, SURELY this is the final straw.

Wait, you mean to tell me that it's now the 11th of December and no one has received a penny yet? Or any idea as to how and when their big payout might be coming?

Well that's done me in lads. I don't think anyone could have seen that coming.

Excellent work from Kelso. This is exactly what a huge number of shareholders want to see happen. Time for MM to stop treating the business like his personal fiefdom, or at least put his money where his mouth is and take it off the public markets.

"Be careful fools"

Physician, heal thyself.

I agree newtonheath - I'm scouring the Johnson & Johnson website and can't find any mention of the deal ANYWHERE. It's baffling. I'd have thought a Fortune 40 multinational would be champing at the bit to spend $275m on fictitious technology from a failed company based in a Caribbean tax haven. I just can't see why it's taking so long.

Happy Friday all!

LOL. Outstanding. Magnificent. Art.

Popping back in to enjoy yet another episode of this, one of the most entertaining soap operas in history. Absolutely made up to see the J&J nonsense getting wheeled out once again, ahead of the 'announcement'. Probably my favourite ever bulletin board delusion.

"Apple is my guess"

LOL.

Well, it's no less absurd than Johnson & Johnson was as a guess, I suppose...

I for one am shocked, SHOCKED, that J&J hasn't been announced as having acquired the business. It all seemed so credible and legitimate. Spare a thought for the last handful of people still clinging on to hope. Poor Hubbas.

There were people here who actually thought that Johnson & Johnson was buying this junk. You have to laugh.

Mind you, it's not difficult to see how some were so easily separated from their cash. They clearly haven't learned their lesson either.

"This really does merit a Netflix miniseries."

Agreed HITS. I saw some activity about this on Twitter and couldn't believe that one of AIM's longest-running soap operas (and history's most credulous investor base) finally seems to be drawing to a close. Cracking bit of storytelling bringing Aberdeenman back for the series finale. Unmissable stuff. If someone could summon up the Greeceball for a cameo as well then we'd really be cooking.

Wouldn't want to be out of this over the weekend.

@Hosai I don't disagree with you on Ocado, ASOS, Boohoo et al. The difference is that those companies have previously 'delivered the goods' - ASOS in particular shot the lights out for years - and are now hitting a rough patch as a result of market conditions. By contrast, THG has consistently underwhelmed from IPO onwards. I'm still holding here, because there's little merit in selling at this point, but the comparison isn't an ideal one. Separately, I think Ocado probably is overvalued, but that's a debate for another board!

I'm not sure it's disproportionate punishment. It's more that this is yet another example of this company falling short of expectations. It seemingly underwhelms every time, without fail. Over time that destroys investor confidence, as we've seen here in spades. It will only take a couple of quarters of exceeding expectations to turn that around and get things moving in the right direction again - plenty of us hoped that would begin today, but it's clearly going to take a while longer.

Indeed. New beginnings. Cautiously excited about the potential of this one.

Just as worthless as those purchased prior to 27th January 2022.